Westlake
Westlake's revenue fell 8.0% to $11.2 billion in fiscal 2025. Its operating margin was −14.1%, down from 7.2% a year earlier. Free cash flow was −$530 million, against $306 million a year earlier. It paid out $335 million in dividends and buybacks. The diluted share count fell 0.7%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2024, earnings per share grew 5.3% a year and net income 5.3% a year, as buybacks cut the share count by 1%. Westlake then lost money in fiscal 2025.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Westlake yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Westlake's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Westlake's 3-year average free cash flow of $359M, net cash of −$2.9B at December 31, 2025 and 128 million diluted shares, from its filings. The scenarios are fitted to Westlake: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -10.9% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 13%: 11% for a cyclical or higher-risk business (Specialty Chemicals), plus 1 point as a smaller company, worth $8.4B, plus 1 point for unsteady results (a loss in fiscal 2025); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target. A negative value means Westlake's net debt is larger than what that scenario's cash flows are worth today.
- Last close, October 26, 2026
- $65.31
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
The P/E method needs positive earnings, and Westlake's latest diluted earnings per share were negative or zero.
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1,908 | 2,228 | 3,304 | 2,919 | 2,724 |
| Debt incl. finance leases | 5,180 | 4,879 | 4,906 | 4,562 | 5,584 |
| Net debt (negative means net cash) | 3,272 | 2,651 | 1,602 | 1,643 | 2,860 |
| Net debt to EBITDA | 0.9x | 0.7x | 0.9x | 0.8x | — |
| Debt to equity | 0.7x | 0.5x | 0.5x | 0.4x | 0.6x |
| Interest coverage | 15.9x | 17.2x | 4.4x | 5.5x | −9.2x |
| Current ratio | 2.2x | 2.6x | 2.4x | 2.8x | 2.2x |
| Quick ratio | 1.6x | 1.8x | 1.8x | 2.0x | 1.6x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Westlake shares on the open market, and 3 insiders sold $10.2 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Albert ChaoExecutive Chairman, Director | Sold | 38,873 | $80.28 | $3.1 million | Form 4 |
| Mar 27, 2026 | Mark Steven BenderEVP & CFO | Sold | 16,413 | $112.54 | $1.8 million | Form 4 |
| Mar 27, 2026 | Robert F. BuesingerEVP, PEM Segment Head | Sold | 4,000 | $115.25 | $461,000 | Form 4 |
| Feb 27, 2026 | Mark Steven BenderEVP & CFO | Sold | 17,409 | $100.92 | $1.8 million | Form 4 |
| Dec 22, 2025 | Albert ChaoExecutive Chairman, Director | Sold | 40,836 | $73.58 | $3.0 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Fail | Pass |
| Gross margin rose | Fail | Fail | Fail |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 5 of 9 | 6 of 9 | 3 of 9 |
| Accruals ratio | −8.9% | −3.4% | −9.7% |
Compare
Put Westlake side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Westlake | FY25 | −8.0% | −14.1% | −4.7% | −10.0% | — | 3 | |
| International Flavors & Fragrances | FY25 | −5.2% | −3.5% | 2.4% | −1.4% | 9.4x | 6 | Compare |
| Celanese | FY25 | −7.0% | −8.2% | 8.4% | −3.7% | — | 5 | Compare |
| Eastman Chemical | FY25 | −6.7% | — | 4.8% | 6.5% | 3.3x | 5 | Compare |
| RPM International | FY26 | 6.7% | — | 8.6% | 13.9% | 1.9x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 5,076 | 8,041 | 8,635 | 8,118 | 7,504 | 11,778 | 15,794 | 12,548 | 12,142 | 11,170 |
| Revenue growth | 4,584.6% | 58.4% | 7.4% | −6.0% | −7.6% | 57.0% | 34.1% | −20.6% | −3.2% | −8.0% |
| Gross profit | 983 | 1,761 | 1,987 | 1,260 | 1,023 | 3,495 | 4,073 | 2,219 | 1,957 | 813 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 583 | 1,225 | 1,408 | 656 | 429 | 2,800 | 3,050 | 729 | 875 | −1,578 |
| Net income | 399 | 1,304 | 996 | 421 | 330 | 2,015 | 2,247 | 479 | 602 | −1,508 |
| Diluted EPS (US$) | 3.06 | 10.00 | 7.62 | 3.25 | 2.56 | 15.58 | 17.34 | 3.70 | 4.64 | −11.70 |
| Diluted shares (millions) | 130 | 130 | 130 | 129 | 128 | 129 | 129 | 129 | 129 | 128 |
| Cash flow | ||||||||||
| Cash from operations | 867 | 1,528 | 1,409 | 1,301 | 1,297 | 2,394 | 3,395 | 2,336 | 1,314 | 465 |
| Capital expenditure | 629 | 577 | 702 | 787 | 525 | 658 | 1,108 | 1,034 | 1,008 | 995 |
| Free cash flow | 238 | 951 | 707 | 514 | 772 | 1,736 | 2,287 | 1,302 | 306 | −530 |
| Dividends paid | 97 | 103 | 120 | 132 | 137 | 145 | 169 | 221 | 264 | 272 |
| Share buybacks | 67 | 0 | 106 | 30 | 54 | 30 | 101 | 23 | 60 | 63 |
| Acquisitions | 2,438 | 13 | 0 | 314 | 0 | 2,554 | 1,203 | 0 | 0 | 0 |
| Stock-based compensation | 14 | 23 | 22 | 25 | 29 | 31 | 36 | 43 | 41 | 41 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 459 | 1,531 | 753 | 728 | 1,313 | 1,908 | 2,228 | 3,304 | 2,919 | 2,724 |
| Debt incl. finance leases | 3,828 | 3,837 | 2,668 | 3,471 | 3,566 | 5,180 | 4,879 | 4,906 | 4,562 | 5,584 |
| Total assets | 10,890 | 12,076 | 11,602 | 13,261 | 13,835 | 18,459 | 20,550 | 21,035 | 20,750 | 19,961 |
| Total liabilities | 6,998 | 6,707 | 5,526 | 6,858 | 7,257 | 9,931 | 10,085 | 10,271 | 9,707 | 10,666 |
| Shareholders' equity | 3,524 | 4,874 | 5,590 | 5,860 | 6,043 | 7,955 | 9,931 | 10,241 | 10,527 | 8,792 |
| Margins and ratios | ||||||||||
| Gross margin | 19.4% | 21.9% | 23.0% | 15.5% | 13.6% | 29.7% | 25.8% | 17.7% | 16.1% | 7.3% |
| Operating margin | 11.5% | 15.2% | 16.3% | 8.1% | 5.7% | 23.8% | 19.3% | 5.8% | 7.2% | −14.1% |
| Net margin | 7.9% | 16.2% | 11.5% | 5.2% | 4.4% | 17.1% | 14.2% | 3.8% | 5.0% | −13.5% |
| Free cash flow margin | 4.7% | 11.8% | 8.2% | 6.3% | 10.3% | 14.7% | 14.5% | 10.4% | 2.5% | −4.7% |
| Return on capital | 8.4% | 16.4% | 13.9% | 6.2% | 4.8% | 21.0% | 19.1% | 4.3% | 4.8% | −10.0% |
| Return on equity | 11.8% | 31.1% | 19.0% | 7.3% | 5.5% | 28.8% | 25.1% | 4.8% | 5.8% | −15.6% |
| Return on assets | 4.8% | 11.4% | 8.4% | 3.4% | 2.4% | 12.5% | 11.5% | 2.3% | 2.9% | −7.4% |
| Net debt to EBITDA | 3.5x | 1.3x | 0.9x | 2.0x | 1.9x | 0.9x | 0.7x | 0.9x | 0.8x | — |